Table 2

Demographic and clinical characteristics of the groups.

Characteristics	Study Group	Control Group	P-value

	Mean±SD n
Gender Female/Male	5/7	6/6	0.682^b
Age	71.83±9.71	72.75±9.23	0.885⁺
H&Y stage 2.5/3	6/6	8/4	0.408^b
Duration	6.83±3.78	6.91±5.07	0.704⁺
Mini Mental Test	28.92±1.17	29.25±1.22	0.383⁺
UPDRS Motor	20.41±7.30	21.66±8.10	0.728⁺
UPDRS ADL	13.25±6.92	12.58±4.68	0.772⁺
*CDP-SOT*
Position 5^th	23.99±28.54	37.99±32.17	0.308⁺
Position 6^th	11.64±23.39	39.1±31.09	0.038⁺
Composite	51.66±13.55	62.33±19.93	0.133⁺
*CDP-Sensory*
SOM	97.67±2.74	94.25±8.67	0.812⁺
VIS	65.00±28.56	70.42±28.60	0.488⁺
VEST	25.66±30.59	41.58±33.89	0.224⁺
PERF	86.08±16.23	89.50±28.39	0.080⁺
*Clinical Balance Tests*
BBS	40.91±7.91	42.17±12.26	0.488⁺
TUG	16.59±8.29	16.75±10.45	0.583⁺
FRT	12.96±3.21	14.41±6.19	0.623⁺

N - Number of subject, SD - standard deviation, H&Y Stage - Modified Hoehn & Yahr Scale, UPDRS - Unified Parkinson Disease Rating Scale, ADL - activities of daily living, β - Chi square test, + - Mann Whitney U test, CDP-SOT - Computerized dynamic posturography – Sensory Organization Test, CDP-Sensory - Computerized dynamic posturography – sensory analysis, SOM - Somatosensory system score, VEST - Vestibular system score, VIS - Visual system score, PREF - Visual preference score, BBS - Berg Balance Scale, TUG - Timed Up and Go Test, FRT - Functional Reach Test